Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

CEN BIOTECH INC (CENBF)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues:  
    Digital  0.6       
Revenues  0.60.02.60.30.30.20.21.4
            Revenue growth   -100.0%779.1%16.7%30.3%-12.4%-83.8% 
Cost of goods sold  1.20.30.00.30.50.20.21.4
Gross profit  -0.6-0.32.60.0-0.20.00.00.0
            Gross margin  -98.3% 98.6%0.0%-87.2%0.0%0.0%0.0%
Selling, general and administrative   [+]16.91.81.22.02.61.00.91.6
Other operating expenses  1.50.53.91.18.80.80.11.4
EBITDA   [+]-18.6-2.1-2.1-2.7-11.2-1.6  
            EBITDA margin  -2963.3% -81.6%-894.1%-4384.9%-823.3%-467.5%-218.8%
Depreciation  0.00.00.00.00.00.0  
EBITA  -18.6-2.1-2.2-2.7-11.2-1.6-1.0-3.0
            EBITA margin  -2966.8% -82.3%-898.9%-4385.6%-824.0%-467.5%-218.8%
Amortization of intangibles  0.40.40.40.40.40.1  
EBIT   [+]-19.0-2.5-2.6-3.1-11.6-1.8-1.0-3.0
            EBIT margin  -3036.9% -98.6%-1041.6%-4552.1%-896.3%-467.5%-218.8%
Non-recurring items   [+]   1.3 4.8  
Interest expense, net   [+]0.02.82.42.01.71.11.20.1
Other income (expense), net   [+]0.119.6-0.7-1.2-0.8-0.6-0.2-0.1
Pre-tax income  -18.914.2-5.7-7.5-14.1-8.2-2.4-3.2
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.2%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -18.914.2-5.7-7.5-14.1-8.2-2.4-3.2
            Net margin  -3015.6% -216.1%-2529.6%-5518.7%-4207.9%-1077.2%-229.8%
   
Basic EPS   [+]($0.45)$0.52($0.21)($0.30)($1.68)($1.20)($0.34)($12.68)
Diluted EPS   [+]($0.45)$0.44($0.21)($0.30)($1.68)($1.20)($0.34)($12.68)
   
Shares outstanding (basic)   [+]42.427.326.425.38.46.97.00.2
Shares outstanding (diluted)   [+]42.432.726.425.38.46.97.00.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy